TABLE OF CONTENTS

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
1.3.1. Immune Repertoire Sequencing Market, by Type, 2015-2025 (USD Billion)
1.3.2. Immune Repertoire Sequencing Market, by Application, 2015-2025 (USD Billion)
1.3.3. Immune Repertoire Sequencing Market, by End-User, 2015-2025 (USD Billion)
1.3.4. Immune Repertoire Sequencing Market, by Region, 2015-2025 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Immune Repertoire Sequencing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Immune Repertoire Sequencing Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Immune Repertoire Sequencing Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Value Chain Analysis
4.3.1. Supplier
4.3.2. Manufacturers/Service Provider
4.3.3. Distributors
4.3.4. End-Users
4.4. Key Buying Criteria
4.5. Regulatory Framework
4.6. Cost Structure Analysis
4.6.1. Raw Material Cost Analysis
4.6.2. Manufacturing Cost Analysis
4.6.3. Labor Cost Analysis
4.7. Investment Vs Adoption Scenario
4.8. Analyst Recommendation & Conclusion
Chapter 5. Immune Repertoire Sequencing Market, by Type
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Key Market Players
5.4. Immune Repertoire Sequencing Market, Sub Segment Analysis
5.4.1. Assay Kits
5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.2. Software & Services
5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 6. Immune Repertoire Sequencing Market, by Application
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Key Market Players
6.4. Immune Repertoire Sequencing Market, Sub Segment Analysis
6.4.1. Biomarker Discovery
6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.2. Infectious Diseases
6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.3. Vaccine Development and Efficacy
6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.4. Cancer Immunotherapy
6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.5. Autoimmune Diseases
6.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.6. Transplant Rejection and Tolerance
6.4.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.7. Others
6.4.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 7. Immune Repertoire Sequencing Market, by End-User
7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Key Market Players
7.4. Immune Repertoire Sequencing Market, Sub Segment Analysis
7.4.1. Academic Institutes
7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2. Research Centers Diagnostic Laboratories
7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3. Others
7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 8. Immune Repertoire Sequencing Market, by Regional Analysis
8.1. Immune Repertoire Sequencing Market, Regional Market Snapshot (2015-2025)
8.2. North America Immune Repertoire Sequencing Market Snapshot
8.2.1. U.S.
8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2. Canada
8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3. Europe Immune Repertoire Sequencing Market Snapshot
8.3.1. U.K.
8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2. Germany
8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3. France
8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.4. Rest of Europe
8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4. Asia Immune Repertoire Sequencing Market Snapshot
8.4.1. China
8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2. India
8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3. Japan
8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4. Rest of Asia Pacific
8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5. Latin America Immune Repertoire Sequencing Market Snapshot
8.5.1. Brazil
8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.2. Mexico
8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6. Rest of The World
8.6.1. South America
8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.6.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.2. Middle East and Africa
8.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.6.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 9. Competitive Intelligence
9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Illumina Inc.
9.3.1.1. Overview
9.3.1.2. Financial (Subject to Data Availability)
9.3.1.3. Product Summary
9.3.1.4. Recent Developments
9.3.2. Pacific Biosciences of California Inc.
9.3.3. Agilent Technologies
9.3.4. Oxford Nanopore Technologies Ltd.
9.3.5. QIAGEN N.V.
9.3.6. Thermo Fischer Scientific
9.3.7. Hoffmann-La Roche Ltd.
9.3.8. BGI
9.3.9. Takara Bio Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.1.6. Research Assumption